Beyond Fundamentals of Hematopoietic Cell Transplantation Training Course
REGISTRATION IS CLOSED
Held in conjunction with the 2017 BMT Tandem Meetings
Dates: February 22 - 23, 2017
Gaylord Palms Convention Center
Kissimmee (Orlando) Florida
|Discounted Price||If Registered By||Refund Policy|
Monday, October 3, 2016
After October 3, 2016
The registration fee includes admission to the Beyond Fundamentals of HCT Training Course, (registration to attend the BMT Tandem Meetings may be done separately) electronic access to the extensive course materials, as well as breakfast and breaks held during the scheduled course activities. Participants are responsible for their own travel and hotel arrangements.
About the Course
This extensive training program provides practitioners with the skills required to care for patients undergoing hematopoietic cell transplantation (HCT), with a focus on pharmacotherapeutic management throughout the transplant process. Registration for this course includes access to the live two-day program with continuing pharmacy education, continuing medical education and nursing continuing education, as well as the comprehensive electronic course book containing more than 1,500 pages of rigorously peer-reviewed clinical information.
New to the live programming will be panel-based discussions about infectious complications and graft-versus-host disease, as well sessions covering busulfan pharmacokinetics, pediatric HCT, pharmacokinetics, pediatric HCT and immune reconstitution.
The course will be offered in conjunction with the 2017 BMT Tandem Meetings. The target audience for this course includes pharmacists, physicians (including residents and hematology/oncology fellows), advanced practice providers and nurses.
Practitioners deriving benefit from this coursework include pharmacists, pharmacy student and residents, registered nurses, advanced practice professionals, and hematology/oncology fellows.
Overall Conference Educational Objectives
After attending the 2017 Beyond Fundamentals of HCT Training Course, participants should be able to:
- Describe the advantages and disadvantages of available strategies for stem cell mobilization.
- Analyze the pharmacologic properties and expected toxicity profiles of medications commonly used in HCT preparative regimens.
- Describe current challenges in managing nausea and vomiting in patients undergoing HCT; outline appropriate monitoring, prevention, and treatment strategies for these patients.
- Assess patient eligibility criteria for HCT based on disease-specific transplantation outcomes.
- Describe strategies available for disease control after HCT.
- Explain interventions to prevent and treat mucositis and maintain nutritional status before and after HCT.
- Define sinusoidal obstructive syndrome (SOS) and associated risk factors; outline prevention and treatment strategies for SOS.
- Summarize common bacterial pathogens and unique approaches to prophylaxis and treatment in patients undergoing HCT.
- Outline the incidence of invasive fungal infections in HCT patients and describe strategies for prophylaxis, empiric therapy, and treatment of documented fungal infections.
- Develop a prophylactic and treatment strategy for common viral infections in HCT patients.
- Evaluate risk factors, prevention strategies, pharmacologic treatment, monitoring guidelines, and supportive care strategies for acute graft-versus-host disease (GVHD).
- Distinguish risk factors, pathophysiology, prevention and treatment strategies, and long-term complications between acute and chronic GVHD.
- Identify and develop a treatment strategy for common pulmonary complications associated with HCT.
- List long-term complications and survivorship challenges experienced by patients undergoing HCT.
- Describe how population pharmacokinetic models are used to support busulfan therapeutic drug monitoring and achievement of desired outcomes in HCT patients receiving busulfan.
- Recognize risk factors, newer diagnostic criteria, and appropriate treatment strategies associated with transplant-associated thrombotic microangiopathy (TA-TMA).
- Outline prevention and treatment strategies for acute and chronic neurologic toxicities caused by either preparative regimens or infectious complications in HCT patients.
- Explain the impact of immune reconstitution on HCT-related outcomes.
- Identify key physiologic changes, risk factors, and benefits that support the need for revaccination in patients who have undergone HCT; formulate a vaccination schedule for a post- HCT patient.
- Evaluate differences in transplant indications and preparative regimen pharmacokinetics and pharmacodynamics when comparing pediatric and adult HCT populations.
Accreditation Statement for Joint Provider Activities:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and American Society for Blood and Marrow Transplantation (ASBMT). The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 16.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 16.25 hours of participation for continuing education for allied health professionals.
Pharmacist Continuing Education Information
View Course announcement
Syntaxx Communications, Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Syntaxx Communications has assigned 16.00 contact hours (1.60 CEUs) of continuing pharmacy education credit for this knowledge- and application-based activity. This 2-day conference will incorporate 22 individual activity sessions that combined will fulfill the 16.00 hours of CE. The target audience for this accredited activity is pharmacists.
To receive continuing pharmacy education credit for the conference, participants must attend the sessions in their entirety and complete the associated program evaluation forms. Additionally, all US-based pharmacists must supply their National Association of Boards of Pharmacy (NABP) electronic Profile Identification (ePID) number and their birth month and day (MM/DD). No credit can or will be issued without this information. To acquire an NABP ePID, go to http://www.nabp.net and click on CPE Monitor.
Universal Activity Numbers
0299-9999-17-014-L01-P – 0299-9999-17-035-L01-P
This 2-day conference will be comprised of 22 individual sessions identified by 22 distinct UAN numbers.
The National Marrow Donor Program is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (COA).
Up to 16 contact hours may be claimed for this educational activity.
Program Evaluation Forms
The program evaluation forms may be accessed and completed online. These forms will be sent to attendees via a link provided by the National Marrow Donor Program. All participants completing program evaluation forms will receive a certificate of attendance provided by the NMDP/BeTheMatch.
For problems or issues related to continuing pharmacy education, please contact Amber Lawson at Syntaxx Communications:
Mail: 305 W Country Dr, Johns Creek, GA 30097
Early registration fees until October 3, 2016 are $425 per person and registration fees after the early registration deadline of October 3, 2016 are $475 per person. No additional fee for the 2-day (February 22, 2017 – February 23, 2017) Beyond Fundamentals of HCT Training Course will be charged to attendees requesting continuing pharmacy education (CPE) credit.
Required Computer Hardware/Software
Registrants are encouraged to bring a computer and print the materials before arriving at the conference. Printers will not be available onsite for conference attendee use. A business center will be available to those willing to pay for copies. This course will use live polling via the 2017 BMT Tandem Meetings mobile app. Access via a mobile device or using the desktop version. Search the App Store or Google Play store for BMT TANDEM MEETINGS (CrowdCompass, Inc). Polling can also be accessed via web browser via the link: https://crowd.cc/bmt2017.
This course is made possible through course registration fees and educational grants from Jazz Pharmaceuticals and the National Marrow Donor Program/Be The Match.
View Course announcement
The Beyond Fundamentals of Hematopoietic Cell Transplantation Training Course is jointly sponsored by the American Society for Blood and Marrow Transplantation and National Marrow Donor Program©/BeTheMatch©